Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
CANCER RISK FROM AZATHIOPRINE...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
CANCER RISK FROM AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE
Bibliographic Details
Main Authors:
Connell, W
,
Kinlen, L
,
Ritchie, J
,
Balkwill, A
,
Lennardjones, J
,
Kamm, M
Format:
Journal article
Published:
1994
Holdings
Description
Similar Items
Staff View
Description
Summary:
Similar Items
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
by: Fraser, A, et al.
Published: (2002)
CYCLOPHOSPHAMIDE, AZATHIOPRINE, AND MALIGNANCY
by: Kinlen, L
Published: (1977)
Increased incidence of azathioprine-induced toxicity in inflammatory bowel diseases compared to other diseases
by: Weersma, R, et al.
Published: (2004)
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
by: Fraser, A, et al.
Published: (2002)
Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease
by: Shizuka Suzuki, et al.
Published: (2023-07-01)